IN BRIEF: Aptamer hails new contract with "top 5 pharma company"
4th Nov 2025 14:33
Aptamer Group PLC - York, England-based synthetic binders developer - Wins new contract with a "top five pharmaceutical company" with a value of up to GBP617,000. It says the contract is the third with this pharmaceutical company and represents "strong validation" of the Optimer platform. Under the agreement, Aptamer will develop Optimer binders against three key drug targets. Further, Aptamer will provide critical support for ELISA assay development. "These tools will enable the partner to validate drug candidates and may also be used to analyse patient samples during clinical trials, potentially leading to clinical diagnostic development," Aptamer says. Read More